Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kopran Ltd

NSE: KOPRAN · BSE: 524280 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹274.55
Market cap
₹1,327 Cr
Revenue (annual)
₹681.4 Cr
Net profit (annual)
₹25.73 Cr
P/E (TTM)
53.1×Sector 47.4×
Promoter holding
44.42%+0.00% QoQ
FII holding
0.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:54 IST BSE
Board Meeting Date

Kopran Board Meeting Date

Kopran Ltd has scheduled a board meeting for August 07, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

15:26 IST BSE
Board Meeting Date

Kopran Board Meeting Date

Kopran Ltd has scheduled a Board Meeting on May 19, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend. The trading window for company securities remains closed until 48 hours after the results declaration.